Orkla's acquisition of Dansk Droge approved

In May 2006, Orkla entered into an agreement to take over all the shares in Dansk Droge. The acquisition is now approved and the deal has been closed. Dansk Droge will play an important part in connection with Orkla's focus on health-related consumer products in the years and months ahead.

Dansk Droge manufactures and markets a wide range of health-related consumer products, including the Futura, Gerimax, Livol and Litozin brands. The company's export sales have been growing in recent years, and its exports to more than 25 countries account for approximately 60 per cent of operating revenues. Dansk Droge primarily distributes its products through grocery stores on the Scandinavian market, while other export markets are mainly served through pharmacies and specialised stores.
Ole Kristian Lunde, SVP Corporate Communications, Tel.:+47- 22 54 44 31